CN104276960A - 盐酸他喷他多和塞来昔布共晶及其组合物和制备方法 - Google Patents
盐酸他喷他多和塞来昔布共晶及其组合物和制备方法 Download PDFInfo
- Publication number
- CN104276960A CN104276960A CN201410500983.5A CN201410500983A CN104276960A CN 104276960 A CN104276960 A CN 104276960A CN 201410500983 A CN201410500983 A CN 201410500983A CN 104276960 A CN104276960 A CN 104276960A
- Authority
- CN
- China
- Prior art keywords
- celecoxib
- eutectic
- tapentadol hydrochloride
- pain
- hydrochloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410500983.5A CN104276960B (zh) | 2014-09-26 | 2014-09-26 | 盐酸他喷他多和塞来昔布共晶及其组合物和制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410500983.5A CN104276960B (zh) | 2014-09-26 | 2014-09-26 | 盐酸他喷他多和塞来昔布共晶及其组合物和制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104276960A true CN104276960A (zh) | 2015-01-14 |
CN104276960B CN104276960B (zh) | 2016-09-28 |
Family
ID=52252364
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410500983.5A Active CN104276960B (zh) | 2014-09-26 | 2014-09-26 | 盐酸他喷他多和塞来昔布共晶及其组合物和制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104276960B (it) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107595792A (zh) * | 2017-11-06 | 2018-01-19 | 刘丽 | 一种盐酸他喷他多塞来昔布片剂及其制备方法 |
CN112807315A (zh) * | 2021-01-18 | 2021-05-18 | 江苏谛奇医药科技有限公司 | 塞来昔布和盐酸他喷他多低共熔混合物、含其的药物组合物及其制备方法和应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050277687A1 (en) * | 2002-11-22 | 2005-12-15 | Gruenenthal Gmbh | Combination of selected analgesics and COX-II inhibitors |
WO2009067706A1 (en) * | 2007-11-21 | 2009-05-28 | Oxigene, Inc. | Method for treating hematopoietic neoplasms |
CN102036946A (zh) * | 2008-05-21 | 2011-04-27 | 埃斯蒂文博士实验室股份有限公司 | 用于治疗疼痛的度洛西汀和Cox-抑制剂的共晶体 |
CN102188365A (zh) * | 2011-05-11 | 2011-09-21 | 中山大学 | 一种难溶性药物共晶固体分散体及其制备方法 |
WO2011151080A1 (en) * | 2010-06-04 | 2011-12-08 | Laboratorios Del Dr. Esteve, S.A. | Pharmaceutical compositions of co-crystals of tramadol and coxibs |
-
2014
- 2014-09-26 CN CN201410500983.5A patent/CN104276960B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050277687A1 (en) * | 2002-11-22 | 2005-12-15 | Gruenenthal Gmbh | Combination of selected analgesics and COX-II inhibitors |
US20130109733A1 (en) * | 2002-11-22 | 2013-05-02 | Gruenenthal Gmbh | Combination of Selected Analgesics and Cox-II Inhibitors |
WO2009067706A1 (en) * | 2007-11-21 | 2009-05-28 | Oxigene, Inc. | Method for treating hematopoietic neoplasms |
CN102036946A (zh) * | 2008-05-21 | 2011-04-27 | 埃斯蒂文博士实验室股份有限公司 | 用于治疗疼痛的度洛西汀和Cox-抑制剂的共晶体 |
WO2011151080A1 (en) * | 2010-06-04 | 2011-12-08 | Laboratorios Del Dr. Esteve, S.A. | Pharmaceutical compositions of co-crystals of tramadol and coxibs |
CN102188365A (zh) * | 2011-05-11 | 2011-09-21 | 中山大学 | 一种难溶性药物共晶固体分散体及其制备方法 |
Non-Patent Citations (4)
Title |
---|
PRZYBYLAK,KATARZYNA R. 等: "How Does the Quality of Phospholipidosis Data Influence the Predictivity of Structural Alerts?", 《JOURNAL OF CHEMICAL INFORMATION AND MODELING》, vol. 54, no. 8, 25 July 2014 (2014-07-25), pages 2224 - 2232, XP 008178071, DOI: doi:10.1021/ci500233k * |
SLAVOV,SVETOSLAV H. 等: "Computational identification of a phospholipidosis toxicophore using 13C and 15N NMR-distance based fingerprints", 《BIOORGANIC & MEDICINAL CHEMISTRY》, vol. 22, no. 23, 27 August 2014 (2014-08-27), pages 6706 - 6714 * |
张正之 等: "新的晶体生长方法-共结晶化", 《化学通报》, no. 4, 1 May 1990 (1990-05-01), pages 18 - 19 * |
许喜林 等: "共结晶技术和应用", 《甘蔗糖业》, no. 6, 25 December 2000 (2000-12-25), pages 33 - 36 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107595792A (zh) * | 2017-11-06 | 2018-01-19 | 刘丽 | 一种盐酸他喷他多塞来昔布片剂及其制备方法 |
CN112807315A (zh) * | 2021-01-18 | 2021-05-18 | 江苏谛奇医药科技有限公司 | 塞来昔布和盐酸他喷他多低共熔混合物、含其的药物组合物及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN104276960B (zh) | 2016-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10377757B2 (en) | Crystal form of JAK inhibitor and preparation method thereof | |
CN102344408B (zh) | 双效麻醉药物 | |
CN103864760A (zh) | 一种盐酸法舒地尔化合物 | |
CN108530425A (zh) | 一种尼拉帕尼对甲苯磺酸盐水合物晶型及其制备方法 | |
US20140275137A1 (en) | Tetrandrine family pharmaceutical formulations and method | |
CN104276960A (zh) | 盐酸他喷他多和塞来昔布共晶及其组合物和制备方法 | |
CN102266343A (zh) | 供注射用盐酸法舒地尔药物组合物 | |
CN101331112B (zh) | 一种联苯乙酸盐及其制备方法与应用 | |
CN104447682A (zh) | 比拉斯汀化合物 | |
CN106511264A (zh) | 一种盐酸哌甲酯口服溶液剂及其制备方法 | |
CN102659905B (zh) | 一种常春藤皂苷元衍生物及其制备方法和应用 | |
US10266523B2 (en) | Crystaline forms of N-[6-(cis-2,6-dimethylmorpholine-4-yl)pyridine-3-yl]-2-Methyl-4′-(trifluoromethoxy) [1,1′-biphenyl]-3-Methanamide monophosphate, and process of preparation thereof | |
CN101669929A (zh) | 一种布洛芬液体制剂的制备方法及其用途 | |
CN105503888B (zh) | 一种盐酸纳洛酮晶型化合物 | |
CN105399719B (zh) | 一种伪麻黄碱类衍生物及其制备方法与应用 | |
WO2021160134A1 (zh) | 3-芳氧基-3-五元杂芳基-丙胺类化合物的制备方法及晶型 | |
WO2022001889A1 (zh) | 去甲曲马多的盐及其用途 | |
CN105037180A (zh) | 一种双重作用的中枢性镇痛新化合物、制备方法及用途 | |
CN103288821A (zh) | 巴马亭衍生物及其制备方法与应用 | |
CN102283824B (zh) | 一种治疗感冒的药物组合物及软胶囊制剂 | |
CN102786462B (zh) | 阿比朵尔盐酸盐晶b型及制法与在药品和保健品中应用 | |
CN105315230A (zh) | 无定型形态的匹维溴铵 | |
CN105439889A (zh) | 一种香兰素胺类新化合物、其制备方法及医药用途 | |
CN104876942A (zh) | 单硝酸异山梨酯半水化合物 | |
CN103830169A (zh) | 一种盐酸法舒地尔注射液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190203 Address after: 230000 No. 15 Weiwu Road, Baohe Industrial Zone, Hefei City, Anhui Province Patentee after: Anhui Heal Star Pharmaceutical Co.,Ltd. Address before: 230051 No. 15 Yan'an Road, Baohe Industrial Zone, Hefei City, Anhui Province Patentee before: Anhui Province Yi Xinming Pharmaceutical Technology Co., Ltd |
|
TR01 | Transfer of patent right |